MedPath

ARTEMIS Synovial Markers in Arthritis Childhood

Not Applicable
Completed
Conditions
Septic Arthritis
Juvenile Idiopathic Arthritis
Interventions
Procedure: Articular punction, salivary samples, blood sample
Registration Number
NCT02505828
Lead Sponsor
University Hospital, Montpellier
Brief Summary

The aim of this study is to find markers that could differentiate infectious and inflammatory arthritis. The investigators want to find markers by differential analysis by compare synovial fluids of septic and inflammatory arthritis. The investigators will use for this analysis, proteomics, cytokine dosage and monocyte typing by flow cytometry analysis. The investigators will use one marker or a score with biological and clinical data to discriminate arthritis of infectious and inflammatory etiology.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Septic arthritis with bacteriological identification
  • Juvenile idiopathic arthritis beyond the ILAR definition
  • Having acute arthritis requiring an articular draining
  • Child benefiting from a national insurance scheme
  • Collection of the consent of the parents or the legal representative
Exclusion Criteria
  • Contraindication in an articular draining: platelet 50 000 / mm3, Rate of prothrombins lower than 70 %, activated partial thromboplastin times (APTT)> 1,5
  • Treatment by biotherapy, corticoids or other immuno suppressor in the month preceding the articular draining.
  • Treatment by antibiotic begun more than 24 hours before the draining.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Septic arthritisArticular punction, salivary samples, blood samplewith bacteriological identification
Juvenile idiopathic arthritisArticular punction, salivary samples, blood samplebeyond the ILAR (International League of Associations for Rheumatology) definition
Primary Outcome Measures
NameTimeMethod
Qualitative analysis of new biological markers (proteic, cytokine or cellular) that discriminate inflammatory and infectious arthritis.1 day

Identify blood sampling biomarkers of Arthritis childhood

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hôpital Arnaud de Villeneuve

🇫🇷

Montpellier, France

© Copyright 2025. All Rights Reserved by MedPath